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Abstract.
Background: Cross-sectional studies of quality of life (QOL) of people with young-onset dementia show diverging results.
Objective: To identify factors associated with QOL in people with young-onset Alzheimer’s (AD) and frontotemporal
dementia (FTD) and explore development in QOL over a two-year period, including differences between the two subtypes.
Methods: A two-year cohort study of 88 community-dwelling people with young-onset AD and FTD recruited from Nordic
memory clinics. QOL was assessed using the proxy version of the Quality of Life – Alzheimer’s Disease questionnaire,
dementia severity was rated with the Clinical Dementia Rating scale, depressive symptoms by the Cornell Scale for Depression
in Dementia, awareness with the Reed anosognosia scale, and needs using the Camberwell Assessment of Needs in the Elderly
questionnaire. Factors associated with QOL and development in QOL over time were explored with growth mixture model
trajectories and mixed model analyses.
Results: We identified two groups of people following trajectories with better (n = 35) versus poorer (n = 53) QOL. People
with more depressive symptoms at baseline had higher odds of belonging to poorer QOL group, OR 1.2 (CI 1.1; 1.5, p = 0.011).
Having Alzheimer’s disease was associated with significantly better QOL (p = 0.047 at baseline, p = 0.009 at T1 and p = 0.033
at T2). Increasing number of unmet needs was significantly associated with poorer QOL at baseline (p = 0.007), but not later
in follow-up.
Conclusion: Early assessment and treatment based on dementia subtype, depression, and individual needs may enhance
quality of life in young-onset dementia.
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INTRODUCTION
Young-onset dementia (YOD) is a term for demen-
tia with symptom debut before the age of 65. Being
diagnosed with dementia at an earlier stage in life
compared to late-onset dementia accentuates chal-
lenges related to partnership and parenthood, shifting
roles and care responsibilities, work and social com-
mitments, financial issues, and future aspirations and
planning [1–3]. As there is still no cure for demen-
tia, knowledge of the determinants of quality of
life (QOL) becomes an important prerequisite in
promoting a good life when living with dementia.
Commonly, the families provide substantial sup-
port and care for prolonged periods of time [4–6].
Therefore, their health and wellbeing must also be
preserved, as the quality of life of the person with
dementia and their informal caregivers appear to be
inter-related [7–10].
Dementia-related functional impairments may be
reflected in poorer quality of life through reduced
self-efficacy, self-esteem, independence, and sense
of autonomy [11]. However, the comprehensive
and highly subjective concept of quality of life
encompasses dimensions of physical, emotional,
psychosocial, and environmental well-being, posing
challenges to objective measurement. Several mod-
els and questionnaires have been constructed since
Lawton introduced the four-dimension model in 1983
consisting of psychological well-being, perceived
quality of life, behavioral competence, and objec-
tive environment [12, 13]. Still, no consensus on how
to define quality of life has been achieved. People
weight various aspects of life differently, and prefer-
ences and values may be modified with age, life stage,
and diseases [14, 15]. Obtaining a reliable measure
of quality of life is further complicated when cogni-
tive impairments affect individuals’ ability to reason
or convey their own perception. The frequent use of
proxy reports introduces new biases, as studies have
shown proxy reports of quality of life to be associ-
ated with informant specific factors, such as caregiver
burden and depression, and that proxy reports are
consistently rated lower than self-reports [16–18].
The diversity of etiologies of young-onset demen-
tia, and the atypical and overlapping symptom pre-
sentation between dementia subtypes, complicates
the diagnostic work-up [19, 20]. About one-third
of individuals with young-onset Alzheimer’s disease
(AD) have an atypical symptom presentation suggest-
ing a distinct neuropsychological profile compared
to the predominant memory problems in late-onset
AD [21, 22]. Such characteristics could affect spe-
cific functional abilities important to quality of life.
Individuals with frontotemporal dementia (FTD),
another major subtype of young-onset dementia, are
more likely to have initial presentation of language
problems, neuropsychological and behavioral symp-
toms, leading to prolonged time-to-diagnosis [19],
and potentially affecting quality of life differently
compared to AD.
Depressive symptoms are prevalent in any stage
of dementia [23]. A Norwegian study detected
depressive symptoms in almost two-thirds of partic-
ipants with young-onset dementia [24]. Depression
interferes with the symptom presentation of demen-
tia and contributes to prolonged time-to-diagnosis
as symptoms are unrecognized or misdiagnosed
[20]. Previous studies have found that depressive
symptoms are associated with increased functional
impairment and healthcare utilization [25], early
institutionalization [5], higher morbidity and mortal-
ity [26], and may even contribute to faster progression
of dementia [27]. Depressive symptoms have consis-
tently been associated with poorer quality of life in
people with dementia, but the magnitude of the asso-
ciations observed is moderate and the proportion of
variance explained is low, indicating that depression
and quality of life are two different constructs [28].
A 2016 review article on psychosocial measures
in young-onset dementia pointed out that quality of
life was the psychosocial domain least often mea-
sured in dementia [29]. Two recent studies showed
that people with young-onset dementia had equally as
good or better quality of life compared to people with
late-onset dementia [16, 30]. However, the published
findings on quality of life have been cross-sectional
and no studies have examined predictors of quality
of life in people with young-onset dementia in a lon-
gitudinal perspective. Thus, the aims of the present
two-year follow-up study were to identify groups of
people with young-onset dementia following similar
trajectories of quality of life and explore factors asso-
ciated to group belonging, and to assess the overall
development in quality of life and factors related to it,
as well as differences in quality of life and explana-
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from memory clinics in Norway, Denmark, and Ice-
land [31]. All participants were community-dwelling
at the time of inclusion. They had a diagnosis of
AD defined by the International Classification of
Diseases-10th revision criteria [32], or FTD accord-
ing to the Neary et al. criteria [33], the International
consensus criteria for behavioral variant-FTD [34],
or the Mesulam criteria [35] for the language variant.
The participants were diagnosed at the memory clin-
ics according to regular diagnostic work-up prior to
study inclusion. The diagnostic assessment and pro-
cedures have previously been shown to be similar
among the memory clinics in an international cooper-
ation in the Nordic Network in Dementia Diagnostics
[36]. Study participation required informed written
consent. A total of 88 participants were recruited, 50
with AD and 38 with FTD, see Fig. 1. They were
included in dyads with a family member who pro-
vided the informant data.
Data collection
The data were collected from 2014 to 2017 in
semi-structured interviews at baseline, and after
one and two years, conducted in parallel with
the person with dementia and the family mem-
ber. Telephone follow-ups were made at six and
18 months. Sociodemographic information, medical
history and medications were recorded. Comprehen-
sive assessments were made based on the manual
of the Norwegian register for persons with cogni-
tive symptoms [37], a collection of standardized and
validated questionnaires and scales commonly used
in dementia assessment. This standardized manual is
incorporated into the diagnostic work-up of all the
included memory clinics in Norway.
Assessment scales and questionnaires
Dementia severity was rated with the Clinical
Dementia Rating scale (CDR) sum of boxes score
for the six scale items, ranging from zero (= no
dementia) to 18 (= severe dementia) [38]. The Mini-
Mental State Examination [39] was used for cognitive
screening, sum score ranging from zero to 30 with
higher score indicating better cognitive function.
Each Nordic country used their respective translated
versions. Depressive symptoms were rated with the
Cornell Scale for Depression in Dementia (CSDD)
[40], sum score ranging from zero to 38 with higher
scores indicating more depressive symptoms. The
Reed anosognosia rating scale [41] for awareness
deficits graded awareness into four categories; 1 = full
awareness, 2 = shallow awareness, 3 = no awareness,
and 4 = denies impairment.
The twelve item Neuropsychiatric Inventory Ques-
tionnaire (NPI-Q) [42] was used for rating of
neuropsychiatric symptoms; the screening of symp-
toms in each domain was followed by a 3-point rating
for severity; 1 = mild, 2 = moderate and 3 = severe.
A severity score for each domain was summarized
into a total NPI score, ranging from zero to 36
with increasing symptom severity. Activities of daily
living (ADL) were assessed using the Lawton and
Brody’s Instrumental Activities of Daily Living scale,
comprising eight items with a sum score ranging
from eight to 31 with increasing impairment [43],
and the Physical Self-Maintenance Scale, compris-
ing six items with a sum score ranging from 6 (no
impairment) to 30 (total impairment). A total ADL
score was summarized from these sum scores, rang-
ing from 14 to 61 points with higher scores indicating
greater functional impairment.
Needs were explored using the Camberwell
Assessment of Needs in the Elderly [44]. This 24-
item questionnaire covers possible problem areas
in everyday life, psychosocial functioning, infor-
mal/formal help needed and received, and met and
unmet needs. The need for help was scored 0 = no
need, 1 = met need, and 2 = unmet need, and the total
number of needs was summarized. The participants
and the family members rated these items indepen-
dently.
The proxy version of the Quality of Life –
Alzheimer’s Disease scale (QOL–AD) [45] was used
to assess quality of life by the family member
applying the “proxy-participant perspective” [46];
i.e, report how the person with dementia would rate
their own quality of life on 13 items; physical health,
energy, mood, living situation, memory, family, mar-
riage, friends, self as a whole, ability to do chores
around the house, ability to do things for fun, money,
and life as a whole. The items were rated on a 4-
point scale from poor to excellent, with a total score
ranging from 13 to 52, higher score indicating better
quality of life.
All measurements were performed at baseline and
at one- and two-year follow-up.
Statistical analyses
The analyses were performed using the SPSS v
24, SAS v 9.4 and STATA v 14. Distribution of vari-
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Fig. 1. Flow chart of the study participants and assessment time points. N = 88. YOD, young-onset dementia; AD, Alzheimer’s disease;
FTD, frontotemporal dementia.
variables are described by their counts and propor-
tions. Continuous variables are represented by their
mean values and standard deviations (SD). Two-sided
independent samples t-test was used for comparison
of continuous variables, and 2-test for categorical
variables. Significance level was set at 5%.
Missing values were imputed using the Replace-
Missing-Values method if less than 15% of items
on a scale were missing and replaced with each par-
ticipant’s own total scale median. Missing values in
the Cornell Scale for Depression in Dementia due
to “not possible to evaluate”, which was ticked off
by almost one in five informants (19%), were set to
zero under the assumption that symptoms/signs that
were not obvious to the family member were most
likely absent. In cases where symptoms in the Neu-
ropsychiatric Inventory Questionnaire were ticked off
as “present” but the severity level was not denoted,
the severity was graded as moderate. Some vari-
ables with many missing values had to be excluded
from the regression analyses due to sample size
considerations.
Linear mixed model with time as fixed effect and
random effects for people nested within study center
was estimated to assess the development in clinical
characteristics. p-values for change from baseline to
one- and two-year follow-up were presented along
with descriptive statistics.
Growth mixture model was estimated to assess
groups of people each following distinct trajectories
of QOL–AD throughout the study period. The Akaike
Information Criterion (AIC) was used to determine
the optimal number of groups. In addition, aver-
age within-group probabilities were expected to be
larger than 0.7, and 95% confidence intervals (CI)
for each trajectory non-overlapping. The identified
groups were then described by bivariate and mul-
tiple regression models with group membership as
dependent variable and selected baseline covariates
as explanatory variables.
Linear mixed model was estimated to explore over-
all time trend in QOL–AD throughout the study
period. The model included random effects for study
center and people nested within center. Random
effects for time were considered in the analysis, but
not included, as the model fit did not improve. Fixed
effects for selected covariates were included into
bivariate and multiple analyses. Interactions between
each covariate and diagnosis (AD or FTD) were
entered in to the model to assess differences between
the diagnostic groups. Also, interactions between
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Both multiple models were reduced by apply-
ing the Akaike Information Criterion. The covariates
were selected based on previous research and inter-
covariate correlation analysis. The same set of
covariates was entered in to both regression models.
Due to strong correlations between several of the vari-
ables explored for the regression analyses, a selection
was made based on correlation analyses. The ini-
tial 26 socio-demographic and clinical covariates
assessed were reduced to nine covariates correlat-
ing weakly or moderately with an inter-correlation
coefficient below r = 0.5 (diagnosis, sex, age, edu-
cation, Clinical Dementia Rating scale, awareness,
Cornell Scale for Depression in Dementia, number
of medications, and self-reported unmet needs).
RESULTS
Of the 88 participants included, 69 (78%) com-
pleted the two-year follow-up, (see Fig. 1). Two
dropouts were due to deceased participants, sixteen
were lost to follow-up due to the total strain on
the families, the family member reporting the par-
ticipant too cognitively impaired for any structured
assessments, or other non-specified reasons. Only
four female participants (10% of all included women)
were lost to follow-up whereas fifteen males (30% of
all included men) discontinued. There were no signif-
icant differences at baseline between the participants
who completed the follow-up and those who dropped
out in age (participant mean age 63 (SD 4.6) versus
dropout 63 (SD 5.3), p = 0.67) education (mean years
13 (SD 3.3) versus 12 (SD 3.3), p = 0.13), diagno-
sis (dropout ratio with AD 9/41 versus FTD 10/28,
Fisher’s Exact p = 0.44), dementia severity (CDR-SB
mean 5 (SD 3.6) versus 4 (SD 2.5, p = 0.29), depres-
sive symptoms (CSDD mean 7 (SD 4.8) versus 8 (SD
7.8), p = 0.35) or QOL–AD scale scores (mean 37 (SD
6.1) versus 35 (SD 8.3), p = 0.57).
During the two-year follow-up there was progres-
sion in dementia severity, functional impairments,
awareness deficits, and cognitive decline, as well as
an increased number of met needs, see Table 1. The
main changes all occurred within the first year of
follow-up.
The trajectories of QOL–AD
The results from the growth mixture analysis are
shown in (Fig. 2). Two groups following distinct
trajectories in QOL–AD, were identified. The aver-
age probabilities were high in both groups (0.92 and
Fig. 2. Two groups of participants with “poorer QOL” (lower
line) versus “better QOL” (upper line) identified from the growth
mixture model. QOL–AD, Quality of Life –Alzheimer’s Disease.
Assessment 1, baseline; assessment 2, One year; and assessment
3, Two years.
0.95, respectively) with non-overlapping confidence
intervals clearly indicating two distinct, homoge-
neous groups of participants. The “better QOL” group
(35 participants) displayed a linear slope and the
“poorer QOL” group (53 participants) a non-linear
slope. The better QOL group had significantly higher
QOL–AD scores at baseline compared to the poorer
QOL group, and this trend persisted throughout the
follow-up period, with both groups showing signif-
icant decline in QOL–AD scores with time. The
parameter estimates for two trajectories with corre-
sponding standard errors and p-values and descriptive
statistics in the QOL groups are shown in Table 2.
The results from the logistic regression analysis
with QOL–AD group membership as the dependent
variable are described in Table 3. According to bivari-
ate analyses, the odds of belonging to the poorer
QOL group were greater among participants with
higher scores on the Clinical Dementia Rating scale
(p = 0.009) and the Cornell Scale for Depression in
Dementia (p = 0.002), and more self-reported unmet
needs (p = 0.037). The same three independent vari-
ables were retained in the multiple model reduced by
Akaike’s Information Criterion; however, the Cornell
Scale for Depression in Dementia was the only sig-
nificant predictor for belonging to the poorer QOL
group, OR 1.2 (CI 1.1; 1.5, p = 0.011).
Overall time trend in QOL–AD and covariates
associated with trend
The results of the linear mixed model are shown
in Table 4. A total of 118 observations were included
across three time points after exclusion of dropouts
and participants with missing data on at least one





















Descriptive data at baseline, one- and two-year follow-up. Means (standard deviations) are given for all continuous variables. p-values were calculated by estimating the linear mixed model and
reported for change from baseline to one-year and from baseline to two-year follow-up (latter not denoted if identical) for YOD combined
Characteristics Baseline One year Two years
N AD N FTD N AD N FTD N AD N FTD p
Participants, n 50 38 44 25 41 8
Age 50 63.3 (4.0) 38 62.7 (5.8) 44 – 25 – 41 – 28 –
Male, n (%) 25 (50) 23 (61) 21 (48) 14 (56) 18 (44) 15 (54)
Education 45 13.3 (3.0) 34 12.8 (3.7) – – – –
MMSE 45 20.6 (5.4) 36 22.9 (7.5) 32 18.6 (5.5) 18 23.1 (6.4) 29 15.5 (7.1) 15 22.5 (7.9) 0.003/<0.001
CDR 50 4.9 (3.5) 38 4.9 (3.4) 42 6.7 (4.7) 21 7.5 (5.0) 39 9.2 (5.2) 21 7.8 (5.4) <0.001
Awareness, n (%) 48 37 37 16 32 20
Intact 36 (75) 15 (40) 21 (57) 6 (38) 12 (38) 7 (35) 0.035/<0.001
Impaired 12 (25) 22 (60) 16 (43) 10 (62) 20 (62) 13 (65)
CSDD 50 6.4 (5.1) 33 7.9 (6.2) 43 7.7 (6.3) 21 8.2 (5.4) 38 7.0 (5.2) 20 8.9 (4.6) 0.163/0.461
NPI 50 5.4 (5.6) 32 9.3 (6.8) 43 6.0 (5.4) 20 7.8 (5.4) 38 7.1 (5.8) 28 9.5 (6.3) 0.884/0.250
ADL 48 21.3 (8.5) 32 21.3 (6.6) 42 25.8 (9.5) 16 27.3 (12.3) 39 26.2 (9.1) 23 24.0 (10.6) 0.001/0.005
Medication 49 2.7 (2.3) 37 3.0 (2.4) 37 2.9 (2.3) 15 3.0 (2.5) 40 3.1 (1.9) 23 3.4 (3.1) 0.728/0.244
Met needsa 47 4.0 (2.4) 32 4.2 (2.5) 37 3.1 (1.9) 12 4.7 (2.7) 22 4.5 (2.5) 8 2.9 (1.2) 0.087/0.828
Unmet needsa 47 0.2 (0.6) 32 0.6 (1.3) 37 0.2 (0.6) 12 0.4 (0.9) 22 0.5 (1.5) 8 1.5 (2.1) 0.752/0.112
QOL–AD 50 37.4 (6.0) 38 34.8 (7.1) 41 36.7 (5.2) 20 33.7 (4.8) 37 35.4 (6.3) 27 32.9 (6.6) 0.137/0.003
AD, Alzheimer’s disease; FTD, frontotemporal dementia; MMSE, Mini Mental State Examination; CDR, Clinical Dementia Rating scale; CSDD, Cornell Scale for Depression in Dementia; NPI,
Neuropsychiatric Inventory Questionnaire; ADL, The Physical Self-Maintenance Scale and Lawton Activities of Daily Living scale total score; QOL–AD, Quality of Life – Alzheimer’s Disease
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Table 2
Baseline characteristics of the two groups of people with “poorer” and “better” QOL, n = 88.
Means (standard deviations) are given for all continuous variables
Poorer QOL group Better QOL group
N = 53 N = 35
Results of growth mixture model
Parameter Estimate (SE) p Estimate (SE) p
Intercept 32.2 (0.8) <0.001 41.6 (0.9) <0.001
Linear 0.007 (0.004) 0.121 –0.003 (0.002) 0.043
Quadratic –0.00001 (0.00001) 0.023
Baseline characteristics in two groups
Variable
Diagnosis
AD, n (%) 26 (49) 24 (69)
FTD, n (%) 27 (51) 11 (31)
Sex
Male, n (%) 28 (523) 20 (57)
Female, n (%) 25 (47) 15 (43)
Age 63.2 (5.0) 62.7 (4.4)
Education 12.6 (3.3) 13.7 (3.3)
CDR 5.9 (3.4) 3.3 (2.9)
Awareness
Intact, n (%) 23 (46) 28 (80)
Impaired, n (%) 27 (54) 7 (20)
CSDD 9.0 (5.9) 4.1 (3.5)
Unmet needs 0.6 (1.16) 0.12 (0.33)
Medication 3.0 (2.4) 2.4 (2.0)
CDR, Clinical Dementia Rating scale; CSDD, Cornell Scale for Depression in Dementia; QOL, Quality of
Life; AD, Alzheimer’s disease; FTD, frontotemporal dementia.
Table 3
Variables associated with poorer QOL group in a logistic regression model
(the better QOL group as reference), n = 69
Characteristics Bivariate models Multiple model, AIC-reduced
OR (95% CI) p OR (95% CI) p
Diagnosis
AD 0.6 (0.2; 1.6) 0.301
Sex
Male 0.9 (0.3; 2.3) 0.747
Age 1.0 (0.9; 1.1) 0.714
Education 1.0 (0.8; 1.1) 0.513
CDR 1.3 (1.1; 1.6) 0.009 1.2 (1.0; 1.4) 0.139
Awareness
Intact 0.4 (0.1; 1.1) 0.063
CSDD 1.3 (1.1; 1.5) 0.002 1.2 (1.1; 1.5) 0.011
Unmet needs 3.0 (1.1; 8.5) 0.037 2.5 (0.9; 7.1) 0.101
Medication 1.0 (0.8; 1.3) 0.882
CDR, Clinical Dementia Rating scale; CSDD, Cornell Scale for Depression in Dementia; QOL,
Quality of Life; AD, Alzheimer’s disease. Reference categories set to frontotemporal dementia,
female and impaired awareness.
we found no significant changes in overall QOL–AD
scores during the two-year period.
In bivariate analyses, higher scores on the Cornell
Scale for Depression in Dementia were significantly
associated with lower QOL–AD scores at baseline
(p = 0.004) but not at later time points, and the
association remained stable over time. More unmet
needs were also significantly associated with lower
QOL–AD scores at baseline (p = 0.011). However,
this association was unstable over time showing
significantly different trend from baseline to two
years (p = 0.025) where QOL increased more with
increasing number of unmet needs while remain-
ing nearly stable among those with no unmet needs.
There was no significant difference between males
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Table 4
Variables associated with QOL–AD time trend, results of the linear mixed model, n = 118
Variables Bivariate models Multiple AIC-reduced model
Regr. Coeff. (SE) p Regr. Coeff. (SE) p
Time
One year –0.6 (0.6) 0.506 21.6 (12.8) 0.100
Two years –0.2 (1.0) 0.854 13.4 (21.9) 0.545
Diagnosis, AD 1.7 (1.6) 0.290 16.6 (8.2) 0.047
Diagnosis, AD × Time
One year 3.1 (1.9) 0.117 5.0 (2.3) 0.034
Two years 2.1 (2.1) 0.321 1.3 (3.5) 0.719
Sex, Male 1.2 (1.6) 0.441 3.9 (2.6) 0.138
Sex, Male × Time
One year 0.7 (1.6) 0.684 –0.4 (2.4) 0.871
Two years –5.1 (1.9) 0.009 –7.4 (2.5) 0.006
Age 0.1 (0.2) 0.693 –0.0 (0.2) 0.996
Age × Time
One year –0.3 (0.2) 0.070 –0.5 (0.2) 0.018
Two years 0.0 (0.2) 0.971 –0.3 (0.3) 0.403
Education 0.2 (0.2) 0.471 0.4 (0.4) 0.299
Education × Time
One year 0.1 (0.3) 0.782 –0.2 (0.4) 0.609
Two years –0.2 (0.3) 0.509 0.6 (0.4) 0.198
CDR –0.2 (0.2) 0.493 0.2 (0.4) 0.643
CDR × Time
One year –0.1 (0.3) 0.741 0.2 (0.4) 0.625
Two years 0.0 (0.4) 0.982 0.1 (3.3) 0.851
Awareness, Intact 1.2 (1.4) 0.395 1.2 (2.8) 0.664
Awareness × Time
One year –0.1 (1.9) 0.970 4.6 (3.3) 0.168
Two years –3.4 (2.2) 0.132 –1.8 (2.8) 0.536
CSDD –0.4 (0.1) 0.004 –0.2 (0.2) 0.125
CSDD × Time
One year 0.2 (0.2) 0.265 0.3 (0.2) 0.168
Two years 0.0 (0.3) 0.952 –0.2 (0.4) 0.590
Unmet needs –1.8 (0.7) 0.011 –2.3 (0.8) 0.007
Unmet needs × Time
One year 1.7 (1.2) 0.168 1.5 (1.4) 0.293
Two years 2.1 (0.9) 0.025 1.4 (1.5) 0.355
Medication –0.1 (0.3) 0.708 0.5 (0.5) 0.363
Medication × Time
One year –0.1 (0.5) 0.847 0.6 (1.4) 0.311
Two years 0.2 (0.5) 0.704 0.0 (0.5) 0.987
Sex × Diagnosis –2.3 (3.2) 0.465
Education × Diagnosis –0.6 (0.5) 0.237
CDR × Diagnosis –0.4 (0.5) 0.377
Awareness × Diagnosis –4.2 (3.1) 0.185
Unmet needs × Diagnosis 0.5 (1.4) 0.730
Medication × Diagnosis –0.7 (0.7) 0.351
AD, Alzheimer’s disease; CDR, Clinical Dementia Rating scale; CSDD, Cornell Scale for Depres-
sion in Dementia. Reference categories set to frontotemporal dementia, female and impaired
awareness.
model, but males had significantly greater reduction
in QOL–AD scores compared to females at two-year
follow-up (p = 0.009).
In the multiple AIC-reduced model, increasing
number of unmet needs was associated with lower
QOL–AD, with association being significant only at
baseline (p = 0.007). As in the bivariate model, there
was no significant difference in overall QOL–AD
time trend between sexes; however, females had
greater increase in QOL–AD scores from baseline
to two-year follow-up compared to males (p = 0.006).
Reduction in QOL-AD from baseline to one year was
significantly greater with increasing age (p = 0.018),
but the overall effect of age on QOL–AD time trend
was non-significant. Participants with AD had sig-







L. Hvidsten et al. / Quality of Life in Young-Onset Dementia 9
compared to FTD (p = 0.047 at baseline, p = 0.009 at
one year and p = 0.033 at two years) with significant
differences between diagnoses in change from base-
line to 1 year (p = 0.034), but not two years. Although
not significant, most interactions with diagnosis were
retained in the AIC-reduced model.
DISCUSSION
To the best of our knowledge, this is the first study
to assess quality of life in people with young-onset
dementia in a longitudinal perspective.
The trajectories of QOL–AD
We identified two groups of people following dis-
tinctly different, homogeneous trajectories of quality
of life in a two-year follow-up study. When adjusting
for group differences at baseline, including demen-
tia severity and unmet needs, the only significant
predictor separating these two groups was sever-
ity of depressive symptoms. For each unit increase
in depressive symptoms on the Cornell Scale for
Depression in Dementia, the odds of belonging to the
poorer QOL group increased by 20%. More depres-
sive symptoms at baseline predicted poorer quality
of life both at baseline and throughout the two-year
follow-up. Our results regarding the significance of
depression to quality of life are in line with the
existing knowledge of predictors of quality of life
in dementia in general and studies of young-onset
dementia [7, 16, 23, 30, 47–49].
To optimize quality of life for people with
young-onset dementia, routine assessment to diag-
nose dementia subtype and co-existing depression
is important for appropriate choices in pharmaco-
logical and psychosocial interventions, including
support services and psychoeducation for people with
dementia and their families. Although the efficacy of
pharmacological treatment of depression in demen-
tia is uncertain [50, 51], a multidisciplinary approach
combining appropriate pharmacological treatment
with psychosocial intervention including the opportu-
nity to engage in meaningful daytime activities, may
have positive impact on mood and several domains
important to quality of life [52, 53]. As depression
in persons with dementia may also be associated
with poorer quality of life in their family members,
the main providers of informal care, ameliorating
depressive symptoms may benefit the whole fam-
ily. Optimizing quality of life within the family
may therefore prolong the opportunity to live at
home—the residency of personal preference, and the
most cost-effective placement in a socio-economic
perspective [54–56].
Overall time trend in QOL–AD and covariates
associated with trend
The longitudinal study design allowed exploration
of QOL–AD trend and associated covariates mea-
sured simultaneously over the two-year period. We
found no significant change in overall quality of life
from baseline to one- and two-year follow-up, which
contradicts the results of significant change within
two groups of people described above. The likely
explanation for this discrepancy is a high degree of
homogeneity within each of the two groups and a
large difference between the groups of people follow-
ing the two distinct trajectories. Due to a markedly
increased heterogeneity in the data set assessed as a
whole, no detectable overall trend was found. Con-
siderable variation in QOL–AD scores has also been
reported in a recent study assessing carers’ perspec-
tives on quality of life in people with young- and
late-onset AD [16]. Family members usually tend to
report poorer quality of life as dementia progresses
while self-reports of QoL are more stable, as people
with dementia seem to put less emphasis on deterio-
ration of cognitive and functional impairments when
evaluating their own quality of life [28, 55, 57–61].
Assuming the result of the time trend analyses show-
ing no significant change was correct, our results
could indicate that family members in the present
study did adhere to the principle of adopting the indi-
vidual’s own perspective, and/or that the dyads shared
rather similar perceptions. Another explanation could
be loss to follow-up of those with greatest deteriora-
tion in quality of life over time, although there were
no significant differences at baseline.
An additionally contrasting result from the linear
mixed model for overall time trend compared to the
logistic regression analysis of the two QOL groups
was the identification of diagnosis as a predictor of
quality of life. Persons with FTD had significantly
poorer quality of life at all time points compared to
persons with AD, but diagnosis was not identified as a
significant predictor of belonging to the poorer QOL
group. The most plausible explanation to this diver-
gence is the use of different statistical methods and
groupings of data. In the linear mixed model, diag-
nosis and QOL–AD were measured simultaneously
at three time points; whereas in the logistic regres-
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(better or poorer QOL), and the diagnosis measured
at baseline was assessed. Since different statistical
methods produced diverging results, the association
between diagnosis and quality of life should be inter-
preted with caution, as also suggested by borderline
significance for diagnosis in the linear mixed model.
Nevertheless, the retaining of non-significant interac-
tions between diagnosis and several other variables
in the multiple model (except for age and depres-
sive symptoms) indicates several possible pathways
by which diagnosis may affect quality of life. The
inclusion of interaction terms with diagnosis and time
were required to determine the effects of diagnosis
and variables associated with time trend. However,
the total number of variables related to sample size
may have caused type II errors, e.g., failure to iden-
tify significant interactions differentiating between
the people with FTD and AD.
Few studies have assessed predictors of quality
of life in people with young-onset dementia, and
they have shown diverging results. Research on older
people with dementia has not identified diagnostic
subtype as a significant determinant to quality of life
[62], which is supported by a recent Dutch study of
nursing home residents with young-onset dementia
[47], but differences in, e.g., etiology, disease sever-
ity, and prevalence of neuropsychiatric symptoms
between nursing home residents and community-
dwelling people with young-onset dementia make
interpretations across study populations difficult [63].
In a larger European multicenter study in which the
baseline data from the present study was included
no significant difference in quality of life between
community-dwelling people with AD and FTD was
found, but diagnosis was retained in the final predic-
tive model for contributing explanatory power [48].
However, the Dutch and the Nordic study populations
differed in their characteristics’ profiles in several
aspects, such as dementia severity, severity of neu-
ropsychiatric symptoms, drug use, and unmet needs,
which might contribute to different impact on quality
of life (unpublished data). As most of the participants
in the present study had mild to moderate degree
of dementia at study inclusion, a possible explana-
tion for poorer quality of life in people with FTD
in this Nordic study population could be related to
problems adapting to change, and greater uncertainty
and distress within the families in the pre-diagnostic
phase [19, 64]. Still, the time-stable observation of
poorer quality of life in this subpopulation through-
out follow-up indicates that additional factors are
involved. Again, the use of proxy QOL–AD may have
biased the results as research has shown that behav-
ioral symptoms are more strongly associated with
poorer quality of life in informant reports than self-
reports [65]. In our analyses, the Neuropsychiatric
Inventory scores were omitted due to high corre-
lations with the Cornell Scale for Depression in
Dementia in the absence of predominant symptom
clusters [30]. Proxy assessments may have skewed
the results further in favor of poorer quality of life for
people with FTD, as it is conceivable that they would
have rated their own quality of life better compared
to people with AD due to reduced awareness of their
condition. This was the case in the Need-YD study
were participants with FTD scored highest on self-
reported QOL–AD of all dementia subtypes, with
greatest discrepancy compared to proxy reports [7].
Apart from a handful of studies the perceived quality
of life of people with FTD remains unexplored.
Depressive symptoms were significantly asso-
ciated with poorer quality of life in bivariate
analysis in the linear mixed model. In the multi-
ple model, depression still showed a negative and
time-stable association with quality of life, how-
ever non-significant. The lack of significance might
be explained by underestimating depression when
scoring the alternative “not possible to evaluate”
in the Cornell scale for Depression in Dementia
to zero, and too low statistical power in the final
model.
Previous research in late-onset dementia has con-
sistently shown unmet needs to be associated with
poorer quality of life [61, 66, 67]. The Need-YD
study did not reach the same conclusion, possibly
for using proxy reports for unmet needs due to dis-
crepancies between informant and self-reports on
prevalence and distribution of (un)met needs. The
present study, based on self-reported needs, found
increasing unmet needs to be associated with poorer
quality of life. Additionally, unmet needs were found
to have negative impact on quality of life through-
out the two-year period for people with AD and FTD
alike. Bakker et al. found that although the dyads
reported lower proportions of unmet to met needs dur-
ing follow-up, there was a strong association between
unmet needs and the level of neuropsychiatric symp-
toms over time, suggesting that unmet care needs and
physical and psychological distress were expressed in
adverse behavioral symptoms, and that unmet needs
had negative influence on the course of symptoms
[68]. As neuropsychiatric symptoms are particu-
larly distressful for the carer, a vicious circle could
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the family member, use of less appropriate coping
strategies, communication failure, dyadic relational
strain, and less tolerance for adverse behavior affect-
ing the quality of care provided, possibly resulting in
more unmet needs within the dyads and escalation
of behavioral problems [69–71]. This underscores
the importance of assessing specific needs in pro-
viding optimal, individualized care in young-onset
dementia [7, 47]. The neuropsychiatric and behav-
ioral disturbances characteristic of FTD can make
available services, such as daytime activities and
psychosocial intervention, ineffective or inappropri-
ate. Premature institutionalization may result due to
chronic distress and fatigue in the families in lack of
respite.
Strengths and limitations
The present study contributes new knowledge in
an emerging research field in young-onset demen-
tia. Participants were recruited from three Nordic
countries, representing slightly different healthcare
service models and organizations, but applying the
same diagnostic work-up. The study population
was relatively homogenous and representative of
community-dwelling people with young-onset AD
and FTD. However, the exclusion of other demen-
tias with additional problems, e.g., alcohol related
dementia, HIV, and Huntington’s disease, could bias
the results in favor of overestimating quality of life,
hence limiting the generalizability of our results. Indi-
viduals who declined participation or were lost to
follow-up likely represent a subgroup with poorer
quality of life, as individuals who partake in stud-
ies are often resourceful, and the total strain on
the participant/families was a frequent reason for
dropout.
Although the present study instructed family mem-
bers to apply the perspectives of the individual with
dementia, it is not possible to eliminate proxy biases
due to informant and relationship-related character-
istics. These are important sources of bias likely to
have contributed to underestimation of the subjec-
tive quality of life and overestimation of deterioration
over time. Requiring a family member as informant
may have excluded a vulnerable group of individu-
als without a supportive network. Also, non-native
minority groups with need for an interpreter were
excluded, limiting the knowledge about additional
cultural barriers.
Conclusion
In this Nordic two-year follow-up study, we
identified two groups of people following trajec-
tories of better versus poorer quality of life, with
more depressive symptoms at baseline predicting
poorer quality of life. In the longitudinal perspec-
tive, being diagnosed with FTD and/or having unmet
needs negatively impacted on development in quality
of life. Timely diagnosis, treatment for depres-
sive symptoms, and early and comprehensive needs
assessments may enhance people’s opportunities in
living well with young-onset dementia.
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